Table 2

Clinicopathological features of HPV-16-positive lung carcinomas

All

N(%)

HPV16 positive

N(%)

HPV16 negative

N(%)

p-value


Age

0.669

< 65 years

38

4 (11)

34 (89)

> 65 years

18

3 (17)

15 (83)

Gender

0.091

Male

43

8 (19)

35 (81)

Female

17

0 (0)

17 (100)

Histology

< 0.001

AC

38

0 (0)

38 (100)

SQC

18

8 (44)

10 (56)

SCLC

4

0 (0)

4 (100)

Differentiation

0.131

Poor

19

5 (26)

14 (74)

Moderate

26

3 (12)

23 (88)

Well

11

0 (0)

11 (100)

Country

0.001

Pakistan

21

7 (33)

14 (67)

China

31

0 (0)

31 (100)

PNG

8

1 (13)

9 (87)


Aguayo et al. Infectious Agents and Cancer 2010 5:20   doi:10.1186/1750-9378-5-20

Open Data